Technical Analysis for ATHE - Alterity Therapeutics Limited
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Down | Up | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| 20 DMA Resistance | Bearish | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| Narrow Range Bar | Range Contraction | -2.86% | |
| Wide Bands | Range Expansion | -2.86% | |
| Oversold Stochastic | Weakness | -2.86% | |
| Stochastic Reached Oversold | Weakness | 1.49% | |
| Outside Day | Range Expansion | 1.49% | |
| Wide Bands | Range Expansion | 1.49% | |
| Down 3 Days in a Row | Weakness | 1.49% |
| Alert | Time |
|---|---|
| 60 Minute Opening Range Breakdown | about 16 hours ago |
| Down 2 % | about 16 hours ago |
| Down 1% | about 16 hours ago |
| 10 DMA Resistance | about 17 hours ago |
| 60 Minute Opening Range Breakout | about 18 hours ago |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/31/2023
Alterity Therapeutics Ltd formerly known as Prana Biotechnology Ltd is active in the healthcare domain. The company is engaged in research collaboration with Takeda for the treatment of Parkinson's disease gastrointestinal neuropathology. The company's lead drug candidate-PBT2 is being developed for the treatment of Alzheimer's and Huntington's diseases. It has also advanced a drug candidate for Parkinson's disease and other movement disorders (PBT434) and brain cancer (PBT519), which are in pre-clinical toxicology testing.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Neuroscience Alzheimer's Disease Gastrointestinal Parkinson's Disease Neurology Toxicology Treatment Of Parkinson's Disease Huntington's Disease Movement Disorders Pathology Anatomical Pathology Brain Cancer Neuropathology Toxicology Testing Treatment Of Alzheimer's
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Neuroscience Alzheimer's Disease Gastrointestinal Parkinson's Disease Neurology Toxicology Treatment Of Parkinson's Disease Huntington's Disease Movement Disorders Pathology Anatomical Pathology Brain Cancer Neuropathology Toxicology Testing Treatment Of Alzheimer's
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 5.41 |
| 52 Week Low | 1.55 |
| Average Volume | 95,136 |
| 200-Day Moving Average | 2.34 |
| 50-Day Moving Average | 1.98 |
| 20-Day Moving Average | 2.22 |
| 10-Day Moving Average | 2.16 |
| Average True Range | 0.25 |
| RSI (14) | 47.92 |
| ADX | 30.62 |
| +DI | 28.33 |
| -DI | 12.37 |
| Chandelier Exit (Long, 3 ATRs) | 2.45 |
| Chandelier Exit (Short, 3 ATRs) | 2.60 |
| Upper Bollinger Bands | 2.69 |
| Lower Bollinger Band | 1.75 |
| Percent B (%b) | 0.31 |
| BandWidth | 42.36 |
| MACD Line | 0.01 |
| MACD Signal Line | 0.05 |
| MACD Histogram | -0.0347 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 2.33 | ||||
| Resistance 3 (R3) | 2.36 | 2.29 | 2.28 | ||
| Resistance 2 (R2) | 2.29 | 2.22 | 2.28 | 2.26 | |
| Resistance 1 (R1) | 2.17 | 2.18 | 2.14 | 2.14 | 2.25 |
| Pivot Point | 2.10 | 2.10 | 2.09 | 2.09 | 2.10 |
| Support 1 (S1) | 1.98 | 2.03 | 1.95 | 1.95 | 1.83 |
| Support 2 (S2) | 1.91 | 1.99 | 1.90 | 1.82 | |
| Support 3 (S3) | 1.79 | 1.91 | 1.80 | ||
| Support 4 (S4) | 1.76 |
